Skip to main content

Table 3 Comparison among economic parameters of two strategies for control of severe asthma (n = 64)

From: Cost-effectiveness analysis of a state funded programme for control of severe asthma

  year before ProAR (US Dollars) year after ProAR (US Dollars)  
  median (quartile) median (quartile) p*
Government annual costs of treatment per patient    
   Cost of outpatient treatment 184 (177/192) 359 (240/471) < 0.01
   Cost of hospital treatment 590 (78/1330) 0 (0/19) < 0.01
   Total annual government costs of treatment 750 (286/1462) 363 (255/481) < 0.01
Family annual costs of treatment and income    
   Family income 2768 (1912/4033) 3280 (2191/5050) 0.02
   Family expenses with asthma (direct cost) 615 (343/1374) 74 (34/275) < 0.01
   Proportion of income spent with asthma 29% 2%  
   Losses for patient and companion (indirect cost) 0 (0/134) 0 (0/0) < 0.01
   Total family costs (direct + indirect) 807 (358/1509) 74 (35/281) < 0.01
  1. * Wilcoxon Signed Rank Tests